| Katie Morris, | |
|
2521 N Elms Rd, Flushing, MI 48433-9423 | |
| (810) 487-5521 | |
| Not Available |
| Full Name | Katie Morris |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 2521 N Elms Rd, Flushing, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164983367 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 4703119396 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Katie Morris, 2521 N Elms Rd, Flushing, MI 48433-9423 Ph: (810) 487-5521 | Katie Morris, 2521 N Elms Rd, Flushing, MI 48433-9423 Ph: (810) 487-5521 |
News Archive
The transplantation of stem cells from a healthy donor (allogeneic) offers the chance of cure for patients with an aggressive form of chronic lymphocytic leukemia (CLL), irrespective of genetic prognostic factors and the prior course of the disease. The German CLL Study Group proved this in a multicentric clinical phase II study led by Professor Dr. Peter Dreger, senior consultant and head of the division of stem cell transplantation at the Department of Internal Medicine V at Heidelberg University Hospital.
Republican and Democratic governors have strikingly different visions for the future of health care, according to a new analysis published in the American Journal of Public Health.
Today, the Food Allergy Safety, Treatment, Education and Research (FASTER) Act, a package of federal policy changes that will improve the health, safety and inclusion of the 32 million Americans living with food allergies, was introduced by Rep. Doris Matsui (D-CA).
Cadence Pharmaceuticals, Inc. today announced the launch of OFIRMEV™ (acetaminophen) injection, the first and only intravenous (IV) formulation of acetaminophen to be approved in the United States. The U.S. Food and Drug Administration (FDA) approved OFIRMEV in November 2010 for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics, and the reduction of fever.
The development of simple and inexpensive generic fixed-dose combined therapies appears the most suitable solution for making possible this access to treatments in developing countries with meagre resources.
› Verified 5 days ago
Tabitha Sudbeck, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2521 N Elms Rd, Flushing, MI 48433 Phone: 810-487-5571 | |
Jayla Fuller, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2521 N Elms Rd, Flushing, MI 48433 Phone: 810-487-5571 | |
Tyree Brown, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2521 N Elms Rd, Flushing, MI 48433 Phone: 810-487-5521 | |
Deborah Derushia, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2521 N Elms Rd, Flushing, MI 48433 Phone: 810-487-5521 | |
Kerri Dubois, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2521 N Elms Rd, Flushing, MI 48433 Phone: 810-487-5571 | |
Kathleen Borchardt, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2521 N Elms Rd, Flushing, MI 48433 Phone: 810-487-5571 | |
Stephanie Gamage, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2521 N Elms Rd, Flushing, MI 48433 Phone: 810-487-5521 |